Skip to main content

Tresiba® (insulin degludec injection)

Tresiba® (insulin degludec injection) is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

Search for Letters

Find documents for this product by entering your search terms in the box below.


Text: double click to edit.

Have a Question?

Request information directly from the Novo Nordisk
Medical Information department.